Viridian Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2015 | 25.0% | 25.0% | -87.8% |
| FY2016 | 27.9% | 27.9% | -69.8% |
| FY2017 | -68.8% | -54.7% | -50.5% |
| FY2018 | -63.7% | -53.3% | -49.4% |
| FY2019 | -265.8% | -178.8% | -138.4% |
| FY2020 | -92.2% | -92.2% | -84.4% |
| FY2021 | -42.3% | -42.3% | -39.0% |
| FY2022 | -32.9% | -32.5% | -29.8% |
| FY2023 | -53.8% | -51.4% | -48.5% |
| FY2024 | -40.2% | -39.0% | -36.4% |
| FY2025 | -47.4% | -47.4% | -38.1% |